Neural‐Immune Interactions in Health and Disease

Abstract: Many lines of research have established the numerous routes by which the immune and central nervous systems (CNS) communicate. The CNS signals the immune system via hormonal and neuronal pathways and the immune system signals the CNS through similar routes via immune mediators and cytokines. The primary hormonal pathway by which the CNS regulates the immune system is the hypothalamic‐pituitary‐adrenal (HPA) axis, through the hormones of the neuroendocrine stress response. The sympathetic nervous system regulates immune system function primarily via adrenergic neurotransmitters released through neuronal routes. Neuroendocrine regulation of immune function is essential for survival during stress or infection and to modulate immune responses in inflammatory disease. Glucocorticoids are the main effector endpoint of the neuroendocrine response system.

[1]  Wolfgang Rauh,et al.  Attenuated Free Cortisol Response to Psychosocial Stress in Children with Atopic Dermatitis , 1997, Psychosomatic medicine.

[2]  J A Gustafsson,et al.  Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. , 1995, Molecular endocrinology.

[3]  K. Madden,et al.  Effects of l-deprenyl treatment on noradrenergic innervation and immune reactivity in lymphoid organs of young F344 rats , 1999, Journal of Neuroimmunology.

[4]  A. Miller,et al.  Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. , 1999, Journal of immunology.

[5]  G. Chrousos,et al.  Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro , 1988, Brain Research.

[6]  R. Dantzer,et al.  Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. , 1995, The American journal of physiology.

[7]  G. Chrousos,et al.  Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease , 1999, Trends in Endocrinology & Metabolism.

[8]  Elaine F. Remmers,et al.  A genome scan localizes five non–MHC loci controlling collagen–induced arthritis in rats , 1996, Nature Genetics.

[9]  David A. Williams,et al.  Murine interleukin‐11 (IL‐11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis , 1996, Journal of cellular physiology.

[10]  R. Gomez-flores,et al.  Suppression of Splenic Macrophage Functions Following Acute Morphine Action in the Rat Mesencephalon Periaqueductal Gray , 1999, Brain, Behavior, and Immunity.

[11]  A. Kaneko,et al.  Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis. , 1999, Arthritis and rheumatism.

[12]  W. Banks,et al.  Passage of cytokines across the blood-brain barrier. , 1995, Neuroimmunomodulation.

[13]  C. Saper,et al.  Mechanisms of CNS response to systemic immune challenge: the febrile response , 1997, Trends in Neurosciences.

[14]  R. Dantzer,et al.  The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Vedhara,et al.  Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination , 1999, The Lancet.

[16]  P. Deuster,et al.  Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1β (IL-1β), IL-6, and Tumor Necrosis Factor-α (TNFα) Production in Humans: High Sensitivity of TNFα and Resistance of IL-6 , 1997 .

[17]  I. Campbell Neuropathogenic actions of cytokines assessed in transgenic mice , 1995, International Journal of Developmental Neuroscience.

[18]  G. Chrousos,et al.  The Stress Response and the Regulation of Inflammatory Disease , 1992, Annals of Internal Medicine.

[19]  D. Felten,et al.  Corticosterone responses of adult Lewis and Fischer rats , 1997, Journal of Neuroimmunology.

[20]  M. Weller,et al.  Maturation‐dependent Modulation of Apoptosis in Cultured Cerebellar Granule Neurons by Cytokines and Neurotrophins , 1996, The European journal of neuroscience.

[21]  J. Sheridan,et al.  Stress-induced modulation of the primary cellular immune response to herpes simplex virus infection is mediated by both adrenal-dependent and independent mechanisms , 1993, Journal of Neuroimmunology.

[22]  D. Payan Neuropeptides and inflammation: the role of substance P. , 1989, Annual review of medicine.

[23]  Jae-Wook Oh,et al.  Interleukin-6 (IL-6) Production by Astrocytes: Autocrine Regulation by IL-6 and the Soluble IL-6 Receptor , 1999, The Journal of Neuroscience.

[24]  M. Wong,et al.  Inducible nitric oxide synthase gene expression in the brain during systemic inflammation , 1996, Nature Medicine.

[25]  S. Wiegand,et al.  Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp , 1987, Journal of neuroscience research.

[26]  P. Sawchenko,et al.  Type 1 interleukin‐1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL‐1–induced cellular activation , 1995, The Journal of comparative neurology.

[27]  D. Mason,et al.  The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. , 1990, Immunology.

[28]  E. O. Johnson,et al.  The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. , 1989, Endocrinology.

[29]  D. Taub,et al.  Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization. , 1998 .

[30]  G. Chrousos,et al.  A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Chrousos,et al.  Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1β and αMSH: studies in rats with different susceptibility to inflammatory disease , 1993, Brain Research.

[32]  S. Maier,et al.  Cytokine-to-brain communication: a review & analysis of alternative mechanisms. , 1995, Life sciences.

[33]  E. Schmidt,et al.  Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  F. Dhabhar,et al.  Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels — a comparison between Sprague-Dawley, Fischer 344 and Lewis rats , 1993, Brain Research.

[35]  D. Pollen,et al.  Altered expression of transforming growth factor-beta in Alzheimer's disease , 1995, Neurology.

[36]  J. Sheridan,et al.  Stress and immunity: implications for viral disease and wound healing. , 1999, Journal of periodontology.

[37]  F. Dhabhar,et al.  Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fischer 344, and Lewis rats , 1995, Journal of Neuroimmunology.

[38]  G. Chrousos,et al.  Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. , 1991, Science.

[39]  F. Holsboer,et al.  Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis , 1999, Journal of Neurology.

[40]  N. Rothwell,et al.  The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. , 1997, The Journal of clinical investigation.

[41]  M. Yokoyama,et al.  Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair. , 1995, Neuroimmunomodulation.

[42]  S. Pillemer,et al.  Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. , 1994, Arthritis and rheumatism.

[43]  R. D. Mellon,et al.  Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity , 1998, Brain Research.

[44]  L. Adorini,et al.  IL-12 production by central nervous system microglia is inhibited by astrocytes. , 1997, Journal of immunology.

[45]  R. Fässler,et al.  The multi-factorial pathogenesis of autoimmune disease. , 1987, Immunology letters.

[46]  S. Felten,et al.  Parallel development of noradrenergic innervation and cellular compartmentation in the rat spleen , 1989, Experimental Neurology.

[47]  D. Goldstein,et al.  Role of CRH in Glucopenia‐lnduced Adrenomedullary Activation in Rats , 1993, Journal of neuroendocrinology.

[48]  E. Sternberg,et al.  Intracerebroventricular Transplantation of Embryonic Neuronal Tissue from Inflammatory Resistant into Inflammatory Susceptible Rats Suppresses Specific Components of Inflammation , 1997, Experimental Neurology.

[49]  G. Glazner,et al.  Interleukin-1 alpha and vasoactive interstinal peptide: Enigmatic regulation of neuronal survival , 1995, International Journal of Developmental Neuroscience.

[50]  J. Sheridan,et al.  Stress-induced changes attributable to the sympathetic nervous system during experimental influenza viral infection in DBA/2 inbred mouse strain , 1994, Journal of Neuroimmunology.

[51]  K. Madden,et al.  Catecholamine influences and sympathetic neural modulation of immune responsiveness. , 1995, Annual review of pharmacology and toxicology.

[52]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[53]  G. Chrousos,et al.  Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. , 1990, Endocrinology.

[54]  J. Satoh,et al.  Interleukin‐15 gene expression in human astrocytes and microglia in culture , 1996, Neuroreport.

[55]  G. Chrousos,et al.  Pituitary-adrenal axis responsiveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. , 1992, The Journal of rheumatology.

[56]  G. Chrousos,et al.  Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Murphy,et al.  Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. , 1989, Endocrinology.

[58]  R. J. Omeljaniuk,et al.  Differential mineralocorticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer rats. , 1994, Neuroimmunomodulation.

[59]  R. Dantzer,et al.  Molecular Basis of Sickness Behavior a , 1998, Annals of the New York Academy of Sciences.

[60]  E. Sternberg,et al.  Corticosteroid resistance and disease. , 1997, Annals of medicine.

[61]  E. Goetzl,et al.  Dual Roles of Substance P: Modulator of Immune and Neuroendocrine Functions a , 1987, Annals of the New York Academy of Sciences.

[62]  T. Dinan,et al.  Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression. , 1998, Life sciences.

[63]  P. Munson,et al.  Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami , 1989, Peptides.

[64]  E. Benveniste Cytokines: influence on glial cell gene expression and function. , 1992, Chemical immunology.

[65]  R. Holmdahl,et al.  Estrogen-mediated immunosuppression in autoimmune diseases , 1998, Inflammation Research.

[66]  G. Chrousos,et al.  Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. , 1988, The Journal of clinical investigation.

[67]  R. Dantzer,et al.  Cytokines and Sickness Behavior , 1998, Annals of the New York Academy of Sciences.

[68]  K. Madden,et al.  Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy , 1994, Journal of Neuroimmunology.

[69]  R. Gaillard Cytokines in the neuroendocrine system. , 1998, International reviews of immunology.

[70]  J. Kiecolt-Glaser,et al.  Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. , 1998, The American journal of medicine.

[71]  F. Bloom,et al.  Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. , 1997, Journal of immunology.

[72]  M. Demitrack,et al.  Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[73]  R. D. Mellon,et al.  The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. , 1999, The Journal of pharmacology and experimental therapeutics.

[74]  N. Rothwell,et al.  Cytokines and the nervous system I: expression and recognition , 1995, Trends in Neurosciences.

[75]  W. Banks,et al.  Relative contributions of peripheral and central sources to levels of IL-1α in the cerebral cortex of mice: assessment with species-specific enzyme immunoassays , 1997, Journal of Neuroimmunology.

[76]  T. Bártfai,et al.  Cytokine Regulation of Neuronal Survival , 1992, Journal of neurochemistry.

[77]  G. Calandra,et al.  Strain and sex variation in the susceptibility to streptococcal cell wall-induced polyarthritis in the rat. , 1982, Arthritis and rheumatism.

[78]  E. Benveniste,et al.  Cytokine actions in the central nervous system. , 1998, Cytokine & growth factor reviews.

[79]  R. Gomez-flores,et al.  Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[80]  P. Deuster,et al.  Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. , 1997, The Journal of clinical endocrinology and metabolism.

[81]  N. Rothwell,et al.  Cytokines and the nervous system II: actions and mechanisms of action , 1995, Trends in Neurosciences.

[82]  G. Chrousos,et al.  Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. , 1988, Neuroendocrinology.

[83]  L. Crofford,et al.  Local Expression of Corticotropin‐Releasing Hormone in Inflammatory Arthritis , 1995, Annals of the New York Academy of Sciences.

[84]  K. Madden,et al.  Noradrenergic Sympathetic Innervation of Lymphoid Organs1 , 1988 .

[85]  S. Lipton Janus faces of NF-κB: Neurodestruction versus neuroprotection , 1997, Nature Medicine.

[86]  P. Barnes,et al.  Anti-inflammatory actions of glucocorticoids: molecular mechanisms. , 1998, Clinical science.

[87]  Mellon Rd,et al.  The Effects of Morphine, Nicotine and Epibatidine on Lymphocyte Activity and Hypothalamic-Pituitary-Adrenal Axis Responses , 1999 .